Relay Therapeutics Inc (RLAY)
4.75
+0.11
(+2.37%)
USD |
NASDAQ |
Nov 22, 16:00
4.74
-0.01
(-0.21%)
Pre-Market: 20:00
Relay Therapeutics Shareholders Equity (Quarterly): 838.86M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 838.86M |
| June 30, 2024 | 681.74M |
| March 31, 2024 | 745.76M |
| December 31, 2023 | 752.00M |
| September 30, 2023 | 778.37M |
| June 30, 2023 | 810.12M |
| March 31, 2023 | 883.41M |
| December 31, 2022 | 950.22M |
| September 30, 2022 | 999.77M |
| June 30, 2022 | 779.64M |
| Date | Value |
|---|---|
| March 31, 2022 | 841.97M |
| December 31, 2021 | 897.81M |
| September 30, 2021 | 571.09M |
| June 30, 2021 | 618.53M |
| March 31, 2021 | 732.79M |
| December 31, 2020 | 763.29M |
| September 30, 2020 | 713.52M |
| June 30, 2020 | -225.39M |
| March 31, 2020 | 335.43M |
| December 31, 2019 | -180.44M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-225.39M
Minimum
Jun 2020
999.77M
Maximum
Sep 2022
664.42M
Average
757.65M
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc | 92.29B |
| Summit Therapeutics Inc | 437.92M |
| Biomarin Pharmaceutical Inc | 5.413B |
| Lexicon Pharmaceuticals Inc | 178.51M |
| Arbutus Biopharma Corp | 106.89M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 930.12M |
| Total Liabilities (Quarterly) | 91.25M |